Clinical trial
Safety and Anti-HIV Activity of Capravirine Alone and in Combination With Other…
NCT00005673 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00005673 |
|---|---|
| Title | Safety and Anti-HIV Activity of Capravirine Alone and in Combination With Other Anti-HIV Drugs |
| Official title | Safety and Pharmacokinetic Study of Capravirine. Part I. Pharmacokinetics of Capravirine in HIV-Negative Volunteers. Part II. Antiviral Activity of Capravirine, Efavirenz, and Abacavir in HIV-Infected Patients |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy, HIV Infection |
| Intervention type | Drug |
| Interventions | Capravirine |
| Enrollment | 46 |
| Start date | May 1, 2000 |
| Completion | May 1, 2002 |
| First posted | May 25, 2000 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: